“…Indeed, such a strategy has been applied in the study of the S. Typhimurium effector SopF (Xu et al, 2019) and the L. pneumophila effector Ceg3/Lpg0080 (Fu, Zhou, et al, 2022;Kubori et al, 2022), though in a more targeted manner as only those Af1521-enriched proteins with the size of interest were analyzed by LC-MS. Notably, Ceg3/Lpg0080 and Larg1/Lpg0081 were found to target ADP/ATP translocases by reversible ADP-ribosylation in host mitochondria to temporally regulate their ADP/ATP exchange activity during L. pneumophila infection (Fu, Li, et al, 2022;Fu, Zhou, et al, 2022;Kubori et al, 2022). Alternatively, the use of an NAD derivative, biotin-17-NAD, in in vitro ADP-ribosylation assays permits streptavidin pull-down of modified ART substrates prior to MS identification.…”